27-hydroxycholesterol has been researched along with Carcinoma, Anaplastic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baek, AE; Chang, CY; Dubois, LG; Gunn, MD; He, S; Kemper, JK; Kwon, S; McDonnell, DP; McDowell, HB; Nelson, ER; Pillai, RV; Sullivan, PM; Thompson, JW; Wardell, SE; Yu, YA | 1 |
1 other study(ies) available for 27-hydroxycholesterol and Carcinoma, Anaplastic
| Article | Year |
|---|---|
The cholesterol metabolite 27 hydroxycholesterol facilitates breast cancer metastasis through its actions on immune cells.
Topics: Animals; Breast Neoplasms; Carcinoma; Cell Line, Tumor; Cholesterol, Dietary; Female; Humans; Hydroxycholesterols; Mice; Mice, Inbred C57BL; Myeloid Cells; Neoplasm Metastasis; Obesity | 2017 |